These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31371977)

  • 1. Cholesterol-embolization syndrome: current perspectives.
    Ozkok A
    Vasc Health Risk Manag; 2019; 15():209-220. PubMed ID: 31371977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol embolization syndrome.
    Saric M; Kronzon I
    Curr Opin Cardiol; 2011 Nov; 26(6):472-9. PubMed ID: 21993354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins.
    Altaf A; Qu P; Zhao Y; Wang H; Lou D; Niu N
    Coron Artery Dis; 2015 Aug; 26(5):409-21. PubMed ID: 25946654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of NLRP3 inflammasome by cholesterol crystals in alcohol consumption induces atherosclerotic lesions.
    Abdul-Muneer PM; Alikunju S; Mishra V; Schuetz H; Szlachetka AM; Burnham EL; Haorah J
    Brain Behav Immun; 2017 May; 62():291-305. PubMed ID: 28232172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions.
    Agrawal A; Ziccardi MR; Witzke C; Palacios I; Rangaswami J
    J Interv Cardiol; 2018 Jun; 31(3):407-415. PubMed ID: 29243285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
    Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
    Freigang S; Ampenberger F; Spohn G; Heer S; Shamshiev AT; Kisielow J; Hersberger M; Yamamoto M; Bachmann MF; Kopf M
    Eur J Immunol; 2011 Jul; 41(7):2040-51. PubMed ID: 21484785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on cholesterol crystal embolism].
    Denis Le Seve J; Gourraud Vercel C; Connault J; Artifoni M
    Rev Med Interne; 2020 Apr; 41(4):250-257. PubMed ID: 32088097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.
    Fukumoto Y; Tsutsui H; Tsuchihashi M; Masumoto A; Takeshita A;
    J Am Coll Cardiol; 2003 Jul; 42(2):211-6. PubMed ID: 12875753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
    Paramel Varghese G; Folkersen L; Strawbridge RJ; Halvorsen B; Yndestad A; Ranheim T; Krohg-Sørensen K; Skjelland M; Espevik T; Aukrust P; Lengquist M; Hedin U; Jansson JH; Fransén K; Hansson GK; Eriksson P; Sirsjö A
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals.
    Boland AJ; Gangadharan N; Kavanagh P; Hemeryck L; Kieran J; Barry M; Walsh PT; Lucitt M
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):509-517. PubMed ID: 29764192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory therapies for cardiovascular disease.
    Ridker PM; Lüscher TF
    Eur Heart J; 2014 Jul; 35(27):1782-91. PubMed ID: 24864079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NLRP3 Inflammasomes in Atherosclerosis.
    Karasawa T; Takahashi M
    J Atheroscler Thromb; 2017 May; 24(5):443-451. PubMed ID: 28260724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy for the treatment of atherothrombosis - inhibition of inflammation.
    Slíva J; Charalambous C; Bultas J; Karetová D
    Physiol Res; 2019 Nov; 68(Suppl 1):S17-S30. PubMed ID: 31755287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cereal Fiber Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by Modulating the NLRP3 Inflammasome Pathway in ApoE
    Zhang R; Han S; Zhang Z; Zhang W; Yang J; Wan Z; Qin L
    J Agric Food Chem; 2018 May; 66(19):4827-4834. PubMed ID: 29664631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
    Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk.
    Mohammadnia N; Opstal TSJ; El Messaoudi S; Bax WA; Cornel JH
    Clin Ther; 2023 Nov; 45(11):1055-1059. PubMed ID: 37716836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet.
    Abderrazak A; Couchie D; Mahmood DF; Elhage R; Vindis C; Laffargue M; Matéo V; Büchele B; Ayala MR; El Gaafary M; Syrovets T; Slimane MN; Friguet B; Fulop T; Simmet T; El Hadri K; Rouis M
    Circulation; 2015 Mar; 131(12):1061-70. PubMed ID: 25613820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
    Bode N; Grebe A; Kerksiek A; Lütjohann D; Werner N; Nickenig G; Latz E; Zimmer S
    Biochem Biophys Res Commun; 2016 Sep; 478(1):356-362. PubMed ID: 27416761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.